News

Walgreens hosts Mobile Photo Hack Day

BY Michael Johnsen

CHICAGO — Walgreens on Saturday will be hosting its first Mobile Photo Hack Day — a contest among mobile photo application developers in creating a "groundbreaking" application using Walgreens’ QuickPrints SDK.

All entries will be reviewed by a panel of notable judges:

  • Kobie Hatcher, solutions director at AIM Consulting, a technology solutions and services company providing resources in flexible configurations;

  • Scott Regan, head of marketing at Apigee, which makes application programming interface products and tools for enterprises and developers;

  • Ari Fuchs, lead API engineer and developer evangelist for Aviary, a company that developed a photo editing platform that allows any developer to instantly inject a photo editor inside their product;

  • Brett Goldstein, commissioner of the Chicago Department of Innovation & Technology. Goldstein, was appointed to the position by Mayor Rahm Emanuel in June 2012 to accelerate Chicago’s growth as a global hub of innovation and technology. He was previously the city’s chief data officer;

  • Kevin McGinnis, VP product platforms at Sprint. McGinnis leads a group responsible for developing platforms and product lines that support customer choice and service enablement;

  • Terry Howerton, founder of TechNexus, a Chicago-based collaboration center that’s home to hundreds of entrepreneurs, startups and growing companies. Howerton also recently co-founded and now chairs the Chicago Tech Academy, a public charter high school teaching entrepreneurship and tech skills to more than 600 inner-city children;

  • Matt Moog, Viewpoints.com CEO, a provider of consumer product reviews. Moog also is the founder of the FireStarter Fund, an early stage investment fund; and

  • Jasbir Patel, Walgreens senior director and general merchandise manager for photo. Patel is part of the senior leadership team at Walgreens.com.

"Hackers" who participate in the all-day event will be competing for $5,000 in cash prizes and complimentary mentoring and residency within TechNexus incubator and collaboration center for six months.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Bounty names winners of ‘Mess Behind Glory’ contest with help from Shawn Johnson, mom

BY Allison Cerra

CINCINNATI — Olympic gold-medal gymnast Shawn Johnson and her mother announced the winners of Bounty’s "Mess Behind the Glory" contest.

Launched back in late April, the contest — which was launched as part of Bounty’s Bring It campaign — asked moms to share 60- to 90-second videos describing their child’s athletic dreams and how they let them “Bring It” for the chance to win prizes that help their children achieve their dreams. Johnson and mother Teri unveiled the names of the top 10 winners, one of whom earned the grand prize, a $5,00 grant. All of the winners received the Ultimate London 2012 Olympic Games Viewing Party, as well as a year’s supply of Bounty.

To see the winning video and learn more about Bounty and the "Bring It" campaign, log on to Bounty’s Facebook page.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Hospira relaunches chemotherapy drug

BY Alaric DeArment

LAKE FOREST, Ill. — Hospira has relaunched a generic chemotherapy drug for the U.S. market, the generic drug maker said Thursday.

The company, which specializes in generic injectables, announced the relaunch of oxaliplatin, a version of Sanofi’s Eloxatin.

Hospira originally launched oxaliplatin in August 2009 after a court ruled in its favor in a patent-infringement suit filed by Sanofi. Sanofi and Hospira later settled the suit in 2010, requiring Hospira to suspend sales of the drug in June 2010, but allowing it to relaunch ahead of the expiration of Sanofi’s patent. The patents on Eloxatin expire between January 2013 and February 2016, according to Food and Drug Administration records.

The Lake Forest, Ill.-based company said the drug had sales of $1.5 billion last year, while IMS Health estimated sales of $1.7 billion for the 12-month period ended in June. Hospira’s launch came the same day as Sagent Pharmaceuticals’ launch of its own generic version of the drug.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?